US
US Prenatal Vitamins Market Industry Trends and Forecast to 2034: Segmented by (Nutrient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $860.5 Mn.
Canada at 7.3% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$429.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $822.7 Mn | — | — |
| 2025 (base) | $860.5 Mn | +$37.8 Mn | — |
| 2026 (forecast) | $900.1 Mn | +$39.6 Mn | +4.6% |
| 2027 (forecast) | $941.5 Mn | +$41.4 Mn | +9.4% |
| 2028 (forecast) | $984.8 Mn | +$43.3 Mn | +14.4% |
| 2029 (forecast) | $1.03 Bn | +$45.3 Mn | +19.7% |
| 2030 (forecast) | $1.08 Bn | +$47.4 Mn | +25.2% |
| 2031 (forecast) | $1.13 Bn | +$49.6 Mn | +31% |
| 2032 (forecast) | $1.18 Bn | +$51.8 Mn | +37% |
| 2033 (forecast) | $1.23 Bn | +$54.2 Mn | +43.3% |
| 2034 (forecast) | $1.29 Bn | +$56.7 Mn | +49.9% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$860.5 Mn
China
$142.9 Mn
Canada
$136.5 Mn
Japan
$131.4 Mn
Germany
$70.5 Mn
France
$58.3 Mn
UK
$51.8 Mn
Brazil
$51.5 Mn
Italy
$43.6 Mn
Ecuador
$37.5 Mn
Saudi Arabia
$35.0 Mn
India
$36.1 Mn
Spain
$33.4 Mn
Mexico
$28.2 Mn
Australia
$26.2 Mn
New Zealand
$21.1 Mn
Russia
$20.4 Mn
South Africa
$13.5 Mn
UAE
$10.2 Mn
Egypt
$5.7 Mn
Philippines
$3.7 Mn
Malaysia
$3.2 Mn
Hong Kong
$2.8 Mn
Thailand
$2.7 Mn
Singapore
$2.1 Mn
Kenya
$1.4 Mn
Prenatal vitamins provide folic acid, iron, iodine, DHA and other nutrients needed before and during pregnancy.
Key segments of the prenatal Vitamins market include nutrient (Folic Acid, Iron and DHA) and form (Tablets and Capsules, Gummies and Powders).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the prenatal Vitamins market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the prenatal Vitamins market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the prenatal Vitamins market.
The prenatal Vitamins market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Food and supplement rules, labelling and health-claim regulations govern prenatal Vitamins products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in US.
What doctors and scientists are doing in Prenatal Vitamins right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
Medical Devices · US
Medical Devices · US
Healthcare Services · US
Healthcare Services · US
Digital Health · US
Pharmaceuticals · US
